Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:52:30.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the 403 error page is otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-12T14:20:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is not accessible at this time. The layout includes a minimal header, a Home link, and a Revision banner, reflecting an error state rather than the usual study details.
    Difference
    17%
    Check dated 2026-09-21T20:12:13.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated from v3.6.5 to v3.6.6. This indicates a minor backend/content update to the page rather than a change to study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-31T17:19:32.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 label was added to the page and the previous Revision: v3.6.4 label was removed, updating the page's version identifier. This reflects an update to the site's software version rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-08-10T12:41:05.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4 in place of the previous v3.6.3, indicating a backend/presentation update without changes to the listed study information.
    Difference
    0.1%
    Check dated 2026-07-27T05:56:31.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.